Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001315863-25-000605
Filing Date
2025-08-13
Accepted
2025-08-13 17:40:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9813
2 jointfilingagmt.htm EX-99.1 7279
  Complete submission text file 0001315863-25-000605.txt   19019
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Subject) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-85963 | Film No.: 251213221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 32 ELM PLACE, 3RD FLOOR RYE NY 10580
Business Address 32 ELM PLACE, 3RD FLOOR RYE NY 10580 917.536.6028
Two Seas Capital LP (Filed by) CIK: 0001823138 (see all company filings)

EIN.: 843799363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G